##### Table of Contents





UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549





FORM 10-K







|x | ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ------------------------------------------------------------------------------

For the fiscal year ended December 31, 2010



| ̈ | TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ----------------------------------------------------------------------------------

For the transition period from  to

Commission file number 001-31275





VERTICAL HEALTH SOLUTIONS, INC.

(Name of small business issuer in its charter)







|                                                                  |  |                                     
|----------------------------------------------------------------- |  | ------------------------------------
|Florida                                                           |  | 59-3635262                          
|(State of or other jurisdiction of
incorporation or organization) |  | (I.R.S. Employer Identification No.)
|                                                                  | 
|180 Douglas Ave., East, Oldsmar, Florida                          |  | 34677                               
|(Address of principal executive offices)                          |  | (Zip Code)                          

Issuers telephone number (813) 403-5050





Securities registered under Section 12(b) of the Exchange Act: None

Securities registered pursuant to Section 12(g) of the Exchange Act: Common Stock





Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities
Act.    Yes   ̈    No  x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.
Yes   ̈    No  x

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act during the past 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    x  YES     ̈  NO

Indicate by check mark whether the registrant has submitted electronically and
posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405) during the preceding 12 months.    Yes   ̈    No   ̈

Check if
there is no disclosure of delinquent filers in response to Item 405 of Regulation S-B contained in this form, and no disclosure will be contained, to the best of registrants knowledge, in definitive proxy of information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the exchange
Act).    Yes  x    No   ̈

Indicate by check mark whether the registrant is a large accelerated filer, and accelerated filer, a non-accelerated filer, or a small reporting company. See definitions of large accelerated
filer, accelerated filer, and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check One):



|                        |  |   |  |                           |  |  
|----------------------- |  | - |  | ------------------------- |  | -
|Large Accelerated Filer |  |  ̈ |  | Accelerated Filer         |  |  ̈
|                        |  |   | 
|Non-accelerated Filer   |  |  ̈ |  | Smaller reporting company |  | x

The
aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant was approximately $58,517 as of the last business day of the registrants most recently completed second fiscal quarter, based upon the
closing sale price on the OTC:BB reported for such date. Shares of common stock held by each officer and director and by each person who owns 10% or more of the outstanding common stock have been excluded in that such persons may be deemed to be
affiliates. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

There were 44,474,973
shares of the Registrants $0.001 par value common stock outstanding as of December 31, 2010.









---

##### Table of Contents

Vertical Health Solutions, Inc.

ANNUAL REPORT ON FORM 10-K

FOR THE FISCAL YEAR ENDED

DECEMBER 31, 2010

TABLE OF CONTENTS



|                                                                                                                     |  |  |    | 
|-------------------------------------------------------------------------------------------------------------------- |  |  | -- | 
|PART I                                                                                                               |  |  |    | 
|Item 1. Business                                                                                                     |  |  | 3  | 
|Item 1A. Risk Factors                                                                                                |  |  | 7  | 
|Item 1B. Unresolved Staff Comments                                                                                   |  |  | 9  | 
|Item 2. Description of Property                                                                                      |  |  | 9  | 
|Item 3. Legal Proceedings                                                                                            |  |  | 9  | 
|Item 4. [Removed and Reserved]                                                                                       |  |  | 9  | 
|                                                                                                                     | 
|PART II                                                                                                              |  |  |    | 
|                                                                                                                     | 
|Item 5. 
Market For Registrants Common Equity Related Stockholder Matters and Issuer Purchases of Equity Securities |  |  | 10 | 
|Item 6. Selected Financial Data                                                                                      |  |  | 10 | 
|Item 7. 
Managements Discussion and Analysis of Financial Condition and Results of Operations                       |  |  | 10 | 
|Item 7A Quantitative and Qualitative Disclosures About Market Risk                                                   |  |  | 11 | 
|Item 8. Financial Statements and Supplementary Data                                                                  |  |  | 11 | 
|Item 9. Changes in and Disagreements With Accountants on Accounting and Financial
Disclosure                         |  |  | 11 | 
|Item 9A. Controls and Procedures                                                                                     |  |  | 12 | 
|Item 9B. Other Information                                                                                           |  |  | 13 | 
|                                                                                                                     | 
|PART III                                                                                                             |  |  |    | 
|                                                                                                                     | 
|Item 10. Directors, Executive Officers, and Corporate Governance                                                     |  |  | 13 | 
|Item 11. Executive Compensation                                                                                      |  |  | 14 | 
|Item 
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters             |  |  | 15 | 
|Item 13. Certain Relationships and Related Transactions, and Director
Independence                                   |  |  | 16 | 
|Item 14. Principal Accounting Fees and Services                                                                      |  |  | 16 | 
|                                                                                                                     | 
|PART IV                                                                                                              |  |  |    | 
|                                                                                                                     | 
|Item 15. Exhibits and Financial Statement Schedules                                                                  |  |  | 16 | 
|                                                                                                                     | 
|SIGNATURES                                                                                                           |  |  | 18 | 



---

##### Table of Contents

Index to Financial Statements

PART I



|Item 1. | DESCRIPTION OF BUSINESS.
|------- | ------------------------

General

In June 2007, Vertical Health Solutions, Inc. completed the sale of its only operating subsidiary, Drug Depot,
Inc. The Company is not actively engaged in any business at the present time and is seeking to develop a new business or secure future acquisitions. Prior to August 2007, the Company, through its wholly-owned subsidiary, operated a Florida retail
and veterinary compounding pharmacy providing specialized compounding pharmaceutical prescription services to veterinarians and their customers in the companion animal sector

Vertical Health Solutions, Inc. was incorporated on March 2000, as a Florida corporation under the name LabelClick.com, Inc. In January 2001, we changed our name to Vertical Health Solutions, Inc. The
Companys executive offices are located at 180 Douglas Ave., East, Oldsmar, Florida 34677 and its telephone number is (813) 403-5060. References in this Annual Report on Form 10-K refer to Vertical Health Solutions, Inc. as the
Company or Vertical, unless the context otherwise requires.

Cautionary Statements for Purposes of The Safe
Harbor Provisions of The Private Securities Litigation Reform Act of 1995

The Private Securities Litigation Reform
Act of 1995 (the Act) provides a safe harbor for forward-looking statements to encourage companies to provide prospective information, so long as such information is identified as forward-looking and is
accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those discussed in the forward-looking statement(s). The Company desires to take advantage of the safe harbor
provisions of the Act.

Except for historical information, the Companys Annual Report on Form 10-K for the year ended
December 31, 2010, the Companys quarterly reports on Form 10-Q, the Companys current reports on Form 8-K, periodic press releases, as well as other public documents and statements, may contain forward-looking statements within the
meaning of the Act.

In addition, representatives of the Company may, from time to time, participate in speeches and calls
with market analysts, conferences with investors and potential investors in the Companys securities, and other meetings and conferences. Some of the information presented in such speeches, calls, meetings and conferences may be forward-looking
within the meaning of the Act.

It is not reasonably possible to itemize all of the many factors and specific events that
could affect the Company and/or the Companys industry as a whole. In some cases, information regarding certain important factors that could cause actual results to differ materially from those projected, forecasted, estimated, budgeted or
otherwise expressed in forward-looking statements made by or on behalf of the Company may appear or be otherwise conveyed together with such statements.

Business  General

The Company, based on proposed business
activities, is a blank check company. The U.S. Securities and Exchange Commission (the SEC) defines those companies as any company that is issuing a penny stock, within the meaning of Section 3(a)(51) of the Exchange Act
of 1934, as amended, (the Exchange Act) and that has no specific business plan or purpose, or has indicated that its business plan is to merge with an unidentified company or companies. Under SEC Rule 12b-2 under the Securities Act of
1933, as amended (the Securities Act), the Company also qualifies as a shell company, because it has no or nominal assets (other than cash) and no or nominal operations. Many states have enacted statutes, rules and
regulations limiting the sale of securities of blank check companies in their respective jurisdictions. Management does not intend to undertake any efforts to cause a market to develop in our securities, either debt or equity, until we
have successfully concluded a business combination. The Company intends to comply with the periodic reporting requirements of the Exchange Act for so long as we are subject to those requirements.



3



---

##### Table of Contents

The analysis of new business opportunities has and will be undertaken by or under the
supervision of the officer and directors of the Company. The Company has unrestricted flexibility in seeking, analyzing and participating in potential business opportunities. In its efforts to analyze potential acquisition targets, the Company will
consider the following kinds of factors:

(a) Potential for growth, indicated by new technology, anticipated market expansion
or new products;

(b) Competitive position as compared to other firms of similar size and experience within the industry
segment as well as within the industry as a whole;

(c) Strength and diversity of management, either in place or scheduled for
recruitment;

(d) Capital requirements and anticipated availability of required funds, to be provided by the Company or from
operations, through the sale of additional securities, through joint ventures or similar arrangements or from other sources;

(e) The cost of participation by the Company as compared to the perceived tangible and intangible values and potentials;

(f) The extent to which the business opportunity can be advanced;

(g) The accessibility of required management expertise, personnel, raw materials, services, professional assistance and other required items; and

(h) Other relevant factors.

In applying the foregoing criteria, no one of which will be controlling, management will attempt to analyze all factors and circumstances and make a determination based upon reasonable investigative
measures and available data. Potentially available business opportunities may occur in many different industries, and at various stages of development, all of which will make the task of comparative investigation and analysis of such business
opportunities extremely difficult and complex. Due to the Companys limited capital available for investigation, the Company may not discover or adequately evaluate adverse facts about the opportunity to be acquired.

Form of Acquisition

The manner in which the Company participates in an opportunity will depend upon the nature of the opportunity, the respective needs and desires of the Company and the promoters of the opportunity, and the
relative negotiating strength of the Company and such promoters.

It is likely that the Company will acquire its participation
in a business opportunity through the issuance of common stock or other securities of the Company. Although the terms of any such transaction cannot be predicted, it should be noted that in certain circumstances the criteria for determining whether
or not an acquisition is a so-called tax free reorganization under Section 368(a)(1) of the Internal Revenue Code of 1986, as amended (the Code), depends upon whether the owners of the acquired business own 80% or more
of the voting stock of the surviving entity. If a transaction were structured to take advantage of these provisions rather than other tax free provisions provided under the Code, all prior stockholders would in such circumstances retain
20% or less of the total issued and outstanding shares. Under other circumstances, depending upon the relative negotiating strength of the parties, prior stockholders may retain substantially less than 20% of the total issued and outstanding shares
of the surviving entity. This could result in substantial additional dilution to the equity of those who were stockholders of the Company prior to such reorganization.



4



---

##### Table of Contents

The present stockholders of the Company will likely not have control of a majority of the
voting shares of the Company following a reorganization transaction. As part of such a transaction, all or a majority of the Companys directors may resign and new directors may be appointed without any vote by stockholders.

In the case of an acquisition, the transaction may be accomplished upon the sole determination of management without any vote or approval
by stockholders. In the case of a statutory merger or consolidation directly involving the Company, it will likely be necessary to call a stockholders meeting and obtain the approval of the holders of a majority of the outstanding shares. The
necessity to obtain such stockholder approval may result in delay and additional expense in the consummation of any proposed transaction and will also give rise to certain appraisal rights to dissenting stockholders. Most likely, management will
seek to structure any such transaction so as not to require stockholder approval.

It is anticipated that the investigation of
specific business opportunities and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments will require substantial management time and attention and substantial cost for accountants, attorneys and
others. If a decision is made not to participate in a specific business opportunity, the costs theretofore incurred in the related investigation would not be recoverable. Furthermore, even if an agreement is reached for the participation in a
specific business opportunity, the failure to consummate that transaction may result in the loss to the Company of the related costs incurred.

Competition

Our primary goal is
the acquisition of a target company or business seeking the perceived advantages of being a publicly held corporation. The Company faces vast competition from other shell companies with the same objectives. The Company is in a highly competitive
market for a small number of business opportunities which could reduce the likelihood of consummating a successful business combination. A large number of established and well-financed entities, including small public companies and venture capital
firms, are active in mergers and acquisitions of companies that may be desirable target candidates for us. Nearly all these entities have significantly greater financial resources, technical expertise and managerial capabilities than we do;
consequently, we will be at a competitive disadvantage in identifying possible business opportunities and successfully completing a business combination. These competitive factors may reduce the likelihood of our identifying and consummating a
successful business combination.

Patent and Trademarks

We currently do not own any patents, trademarks or licenses of any kind.

Government
Regulations

There are no government approvals necessary to conduct our current business.

Employees

We presently have no
employees. Our officer and directors are engaged in outside business activities and we anticipate that they will devote to our business very limited time until the acquisition of a successful business opportunity has been identified. We expect
no significant changes in the number of our employees other than such changes, if any, incident to a business combination.

Material
Developments

On February 1, 2011, the Company entered into an Agreement and Plan of Merger (the Merger
Agreement), by and among OnPoint Medical Diagnostics, Inc., a Minnesota corporation (OnPoint), the Company and Vertical HS Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of VHS (Merger Sub).
Pursuant to the Merger Agreement, on the closing date of the merger, the Merger Sub will merge with and into OnPoint, which will be the surviving company and a wholly-owned subsidiary of the Company (the Merger).



5



---

##### Table of Contents

OnPoint was founded to commercialize Magnetic Resonance Imaging Quality Assurance software
and technologies developed by the Mayo Clinic. OnPoint is a development stage company leveraging technology and intelligent systems to assist the healthcare industry in delivering high quality medical images in a safe, consistent and efficient
manner. These technology and intelligent systems are delivered in a Software-as-a-Service (SaaS) model, deployed in the cloud and exceed the accreditation standards required by law. OnPoint believes its comprehensive software service detects gradual
degradation in image quality, saves time and money by improving consistency and reliability, and facilitates proactive preventative maintenance that minimizes unplanned downtime.

As a condition to the Merger Agreement, the Company must complete a reverse stock split of its outstanding shares of common stock on a
one-for-164 basis prior to closing of the Merger (the Reverse Stock Split), such that immediately prior to the Merger, the Company will have no more than 1,084,756 shares of common stock outstanding. As of the date of filing of this Form
10-K, the Reverse Stock Split has not been effectuated. Pursuant to the Merger Agreement, upon completion of the Merger, the Company will issue an aggregate of 7,143,113 post reverse split shares of the Companys common stock (the
Acquisition Shares) to the shareholders of OnPoint in exchange for 100% of the issued and outstanding capital stock of OnPoint. In addition, up to 2,803,847 post reverse split shares of the Companys common stock may be issued upon
conversion of outstanding OnPoint promissory notes (at an assumed conversion price of $0.65 per share), up to 264,250 post reverse split shares of the Companys common stock may be issued upon exercise of warrants currently issued to purchase
OnPoint common stock (at an exercise price of $1.00 per share), and up to 800,000 post reverse split shares of the Companys common stock may be issued upon exercise of options currently issued to purchase OnPoint common stock (at an exercise
price of $1.00 per share). Of the 7,143,113 post reverse split Acquisition Shares, 1,000,000 post reverse split shares will be placed in escrow. Such shares will be released to the OnPoint stockholders in the event the Company completes an aggregate
of $1,000,000 of equity financing on or before December 31, 2011. If such financing is not completed on or before December 31, 2011, the 1,000,000 post reverse split shares will be cancelled.

Upon consummation of the Reverse Stock Split, the holders of certain promissory notes and other Company obligations aggregating $150,000
(the VHS Promissory Notes) will convert such notes into 813,567 post reverse split shares of the Companys common stock.

The Companys obligation to complete the Merger is subject to the fulfillment or waiver by the Company of customary conditions contained in the Merger. OnPointss obligation to complete the
Merger is subject to the fulfillment or waiver by OnPoint of the conditions contained in the Merger Agreement including, but not limited to, the following conditions:



| |  | the Company shall have completed the Reverse Stock Split;
|- |  | ---------------------------------------------------------



| |  | the VHS Promissory Notes shall have been converted into shares of the Companys common stock;
|- |  | ---------------------------------------------------------------------------------------------



| |  | OnPoint shall have completed a private placement pursuant to which it receives gross proceeds of at least $500,000;
|- |  | -------------------------------------------------------------------------------------------------------------------



| |  | all outstanding liabilities of the Company shall have been satisfied, other than amounts of up to $50,000;
|- |  | ----------------------------------------------------------------------------------------------------------



| |  | OnPoint stockholders shall have approved the Merger;
|- |  | ----------------------------------------------------



| |  | subject to appropriate filings under the Securities and Exchange Act of 1934, as amended, the current officers and directors of the Company shall have
resigned and officers and directors designated by OnPoint shall have been appointed to the Companys Board of Directors and as officers of the Company.
|- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The Merger Agreement may be terminated by either party if the Merger has not been consummated by March 31, 2011. The Merger Agreement may be terminated by the Company if the representations or
warranties provided by OnPoint become inaccurate. The Merger Agreement may be terminated by OnPoint if:



| |  |  | The representations or warranties provided by the Company become inaccurate;
| | - |  | ----------------------------------------------------------------------------



| |  |  | OnPoints due diligence investigation reveals information which varies materially or adversely from the understandings upon which OnPoint agreed
to proceed with the Merger;
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | More than 5% of the OnPoint stockholders exercise dissenters rights; or
| | - |  | ------------------------------------------------------------------------



6



---

##### Table of Contents

| |  |  | The Company has suffered any material adverse change from the date of signing the Merger Agreement
| | - |  | --------------------------------------------------------------------------------------------------

Closing of the transactions contemplated by the Merger Agreement is subject to other customary terms and conditions. The foregoing
description of the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the Merger Agreement, which is filed as an exhibit to this Current Report on Form 8-K filed on February 7, 2011.



|Item 1A. | RISK FACTORS.
|-------- | -------------

RISK
FACTORS

Our business is difficult to evaluate because we have a limited operating history.

As the Company has no operating revenue and only minimal assets, there is a risk that we will be unable to continue as a going concern
and consummate a business combination. The Company has had no recent operating history nor any recent revenues or earnings from operations. We have no significant assets or financial resources. We will, in all likelihood, sustain operating expenses
without corresponding revenues, at least until the consummation of a business combination. This may result in our incurring a net operating loss that will increase continuously until we can consummate a business combination with a profitable
business opportunity. We cannot assure you that we can identify a suitable business opportunity and consummate a business combination.

There is competition for those private companies suitable for a merger transaction of the type contemplated by management.

The Company is in a highly competitive market for a small number of business opportunities which could reduce the likelihood of
consummating a successful business combination. We are and will continue to be an insignificant participant in the business of seeking mergers with, joint ventures with and acquisitions of small private and public entities. A large number of
established and well-financed entities, including small public companies and venture capital firms, are active in mergers and acquisitions of companies that may be desirable target candidates for us. Nearly all these entities have significantly
greater financial resources, technical expertise and managerial capabilities than we do; consequently, we will be at a competitive disadvantage in identifying possible business opportunities and successfully completing a business combination. These
competitive factors may reduce the likelihood of our identifying and consummating a successful business combination.

Future success is
highly dependent on the ability of management to locate and attract a suitable acquisition.

The nature of our operations
is highly speculative and there is a consequent risk of loss of your investment. The success of our plan of operation will depend to a great extent on the operations, financial condition and management of the identified business opportunity. While
management intends to seek business combination(s) with entities having established operating histories, we cannot assure you that we will be successful in locating candidates meeting that criterion. In the event we complete a business combination,
the success of our operations may be dependent upon management of the successor firm or venture partner firm and numerous other factors beyond our control.

Management intends to devote only a limited amount of time to seeking a target company which may adversely impact our ability to identify a suitable acquisition candidate.

While seeking a business combination, management anticipates devoting no more than a few hours per week to the Companys affairs in
total. Our sole officer has not entered into a written employment agreement with us and are not expected to do so in the foreseeable future. This limited commitment may adversely impact our ability to identify and consummate a successful business
combination.

The time and cost of preparing a private company to become a public reporting company may preclude us from entering into a
merger or acquisition with the most attractive private companies.

Target companies that fail to comply with SEC reporting
requirements may delay or preclude acquisition. Sections 13 and 15(d) of the Exchange Act require reporting companies to provide certain information about significant acquisitions, including certified financial statements for the company acquired,
covering one, two, or



7



---

##### Table of Contents

three years, depending on the relative size of the acquisition. The time and additional costs that may be incurred by some target entities to prepare these statements may significantly delay or
essentially preclude consummation of an acquisition. Otherwise suitable acquisition prospects that do not have or are unable to obtain the required audited statements may be inappropriate for acquisition so long as the reporting requirements of the
Exchange Act are applicable.

The Company may be subject to further government regulation which would adversely affect our operations.

Although we will be subject to the reporting requirements under the Exchange Act, management believes we will not be
subject to regulation under the Investment Company Act of 1940, as amended (the Investment Company Act), since we will not be engaged in the business of investing or trading in securities. If we engage in business combinations which
result in our holding passive investment interests in a number of entities, we could be subject to regulation under the Investment Company Act. If so, we would be required to register as an investment company and could be expected to incur
significant registration and compliance costs. We have obtained no formal determination from the SEC as to our status under the Investment Company Act and, consequently, violation of the Investment Company Act could subject us to material adverse
consequences.

Any potential acquisition or merger with a foreign company may subject us to additional risks.

If we enter into a business combination with a foreign concern, we will be subject to risks inherent in business operations outside of
the United States. These risks include, for example, currency fluctuations, regulatory problems, punitive tariffs, unstable local tax policies, trade embargoes, risks related to shipment of raw materials and finished goods across national borders
and cultural and language differences. Foreign economies may differ favorably or unfavorably from the United States economy in growth of gross national product, rate of inflation, market development, rate of savings, and capital investment, resource
self-sufficiency and balance of payments positions, and in other respects.

There are issues impacting liquidity of our securities with
respect to the SECs review of a future resale registration statement.

Since our shares of common stock issued prior
to a business combination or reverse merger cannot currently, nor will they for a considerable period of time after we complete a business combination, be available to be offered, sold, pledged or otherwise transferred without being registered
pursuant to the Securities Act, we will likely file a resale registration statement on Form S-1, or some other available form, to register for resale such shares of common stock. We cannot control this future registration process in all
respects as some matters are outside our control. Even if we are successful in causing the effectiveness of the resale registration statement, there can be no assurances that the occurrence of subsequent events may not preclude our ability to
maintain the effectiveness of the registration statement. Any of the foregoing items could have adverse effects on the liquidity of our shares of common stock.

We have never paid dividends on our common stock.

We have never paid
dividends on our common stock and do not presently intend to pay any dividends in the foreseeable future. We anticipate that any funds available for payment of dividends will be re-invested into the Company to further its business strategy.

The Company may be subject to certain tax consequences in our business, which may increase our cost of doing business.

We may not be able to structure our acquisition to result in tax-free treatment for the companies or their stockholders, which could
deter third parties from entering into certain business combinations with us or result in being taxed on consideration received in a transaction. Currently, a transaction may be structured so as to result in tax-free treatment to both companies, as
prescribed by various federal and state tax provisions. We intend to structure any business combination so as to minimize the federal and state tax consequences to both us and the target entity; however, we cannot guarantee that the business
combination will meet the statutory requirements of a tax-free reorganization or that the parties will obtain the intended tax-free treatment upon a transfer of stock or assets. A non-qualifying reorganization could result in the imposition of both
federal and state taxes that may have an adverse effect on both parties to the transaction.



8



---

##### Table of Contents

Our business will have no revenues unless and until we merge with or acquire an operating business.

We are a shell company and have had no revenues from operations. We may not realize any revenues unless and until we
successfully merge with or acquire an operating business.

The Company intends to issue more shares in a merger or acquisition, which will
result in substantial dilution.

Our Certificate of Incorporation authorizes the issuance of a maximum of
250,000,000 shares of common stock and a maximum of 4,000,000 shares of preferred stock. Any merger or acquisition effected by us may result in the issuance of additional securities without stockholder approval and may result in substantial
dilution in the percentage of our common stock held by our then existing stockholders. Moreover, the common stock issued in any such merger or acquisition transaction may be valued on an arbitrary or non-arms-length basis by our management,
resulting in an additional reduction in the percentage of common stock held by our then existing stockholders. Our Board of Directors has the power to issue any or all of such authorized but unissued shares without stockholder approval. To the
extent that additional shares of common stock or preferred stock are issued in connection with a business combination or otherwise, dilution to the interests of our stockholders will occur and the rights of the holders of common stock might be
materially and adversely affected.

The Company has conducted no market research or identification of business opportunities, which may
affect our ability to identify a business to merge with or acquire.

The Company has neither conducted nor have others
made available to us results of market research concerning prospective business opportunities. Therefore, we have no assurances that market demand exists for a merger or acquisition as contemplated by us. Our management has not identified any
specific business combination or other transactions for formal evaluation by us, such that it may be expected that any such target business or transaction will present such a level of risk that conventional private or public offerings of securities
or conventional bank financing will not be available. There is no assurance that we will be able to acquire a business opportunity on terms favorable to us. Decisions as to which business opportunity to participate in will be unilaterally made by
our management, which may act without the consent, vote or approval of our stockholders.



|Item 1B. | UNRESOLVED STAFF COMMENTS.
|-------- | --------------------------

None.



|Item 2. | DESCRIPTION OF PROPERTY.
|------- | ------------------------

As of December 31, 2010, the Company had no real property, equipment, furniture, and leasehold improvements.



|Item 3. | LEGAL PROCEEDINGS.
|------- | ------------------

The
Company is not currently a party to any other legal proceeding, which it believes will have a material adverse affect on its results of operations.



|Item 4. | [REMOVED AND RESERVED].
|------- | -----------------------



9



---

##### Table of Contents

PART II



|Item 5. | MARKET FOR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
|------- | ------------------------------------------------------------------------------------------------

Market for Securities

In
January 2004, the Companys common stock began trading on the OTC Bulletin Board under the symbol VHSL. There is a limited trading market for the Companys stock; therefore historical price information is limited. High and low
sales prices since that time, by quarter-ended date, are as follows:



|                   |  |      |       |  |     |   |       | 
|------------------ |  | ---- | ----- |  | --- | - | ----- | 
|                   |  | High |       |  | Low |  
|March 31, 2009     |  | $    | 0.011 |  |     | $ | 0.005 | 
|June 30, 2009      |  | $    | 0.006 |  |     | $ | 0.005 | 
|September 30, 2009 |  | $    | 0.18  |  |     | $ | 0.006 | 
|December 31, 2009  |  | $    | 0.02  |  |     | $ | 0.005 | 
|                   |  |     
|March 31, 2010     |  | $    | 0.08  |  |     | $ | 0.011 | 
|June 30, 2010      |  | $    | 0.06  |  |     | $ | 0.015 | 
|September 30, 2010 |  | $    | 0.048 |  |     | $ | 0.022 | 
|December 31, 2010  |  | $    | 0.025 |  |     | $ | 0.012 | 

As of
December 31, 2010, there were approximately 259 stockholders of record of the Companys common stock.

Dividend Policy

Historically, the Company has not declared or paid any cash dividends on its common stock. Any future determination to pay
dividends on its common stock will depend upon the Companys results of operations, financial condition and capital requirements, applicable restrictions under any contractual arrangements and such other factors deemed relevant by the
Companys Board of Directors.

Recent Sales of Unregistered Securities:

None.



|Item 6. | Selected Financial Data.
|------- | ------------------------

Not
applicable.



|Item 7. | MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
|------- | --------------------------------------------------------------------------------------

The statements contained in this Report that are not historical are forward-looking statements, including statements regarding the
Companys expectations, intentions, beliefs or strategies regarding the future. Forward-looking statements include the Companys statements regarding liquidity, anticipated cash needs and availability and anticipated expense levels. All
forward-looking statements included in this Report are based on information available to the Company on the date hereof, and the Company assumes no obligation to update any such forward-looking statements. It is important to note that the
Companys actual results could differ materially from those in such forward-looking statements. Additionally, the following discussion and analysis should be read in conjunction with the Financial Statements and notes thereto appearing
elsewhere in this Report. The discussion is based upon such financial statements, which have been prepared in accordance with U.S. Generally Accepted Accounting Principles.

Overview

The Company is currently operating as a public shell and does not
generate revenues or produce products.

Selling, general and administrative costs include professional fees and consulting
expenses and other minor costs.



10



---

##### Table of Contents

Results of Operations

Year Ended December 31, 2010 Compared To Year Ended December 31, 2009

Operating expenses. The Company incurred operating expenses of $80,576 for the year ended December 31, 2010, an increase of $23,935 or 42%, compared to $56,641 for the year ended
December 31, 2009. The increase was primarily attributable to the lack of operations in 2010 and search for a merger candidate.

Interest expense, net of interest income. Interest income, net of interest expense was $1,097 for the year ended December 31, 2010 as compared to $0 for the year ended December 31, 2009.
The increase in interest expense is due to a loan from a shareholder to pay operating expenses until a merger candidate could be secured.

Income taxes. The Company had no income tax provision for the years ended December 31, 2010 and 2009. No tax benefit has been provided due to the uncertainty in the utilization of the loss
carry forwards. These net operating losses may be carried forward for up to 20 years.

Preferred dividends. Preferred
dividends on the Companys preferred stock were $0 for the years ended December 31, 2010 and December 31, 2009.

Net loss per share.Net loss per share was $0.00 for the year ended December 31, 2010, compared to net loss per share of
$0.00 for the year ended December 31, 2009.

Inflation; Seasonality.Management believes that there was no
material effect on operations or the financial condition of the Company as a result of inflation for the years ended December 31, 2010 and 2009. Management also believes that its business is not seasonal; however, significant promotional
activities can have a direct impact on sales volume in any given quarter.

Financial Condition, Liquidity and Capital
Resources

The Company had cash of $4,856 and a working capital deficit of $197,012 at December 31, 2010, compared
to cash of $2,932 and a working capital deficit of $116,436 at December 31, 2009.

Net cash used by operating activities
was $38,446 for the year ended December 31, 2010, as compared to net cash used in operating activities of $90,976 for the year ended December 31, 2009.

Net cash provided by investing activities was $0 for the years ended December 31, 2010 and 2009.

Net cash provided by financing activities was $40,370 for the year ended December 31, 2010, as compared to $93,908 for the year ended December 31, 2009. The decrease in cash provided by
financing activities is primarily due the decrease in proceeds from notes or stockholders during the year ended December 31, 2010.

The Companys future liquidity and cash requirements will primarily depend on the Companys ability to develop a new business or secure future acquisitions. In particular, as the Company will
not have any cash flows from operations, it will be necessary for the Company to raise capital or seek additional financing. While there can be no assurance that such raising of capital or seeking of additional financing would be available in
amounts and on terms acceptable to the Company, management believes that such financing would likely be available on acceptable terms.



|Item 7A. | QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.
|-------- | ----------------------------------------------------------

Not applicable.



|Item 8. | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
|------- | --------------------------------------------

See financial statements following Item 15 of this Annual Report on Form 10-K.



|Item 9. | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.
|------- | -------------------------------------------------------------------------------------

None.



11



---

##### Table of Contents

|Item 9A. | CONTROLS AND PROCEDURES.
|-------- | ------------------------

Disclosure
Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we carried out
an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Management conducted its evaluation based on the framework in
Internal Control  IntegratedFramework issued by the Committee on Sponsoring Organizations of the Treadway Commission (COSO). Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that, at
December 31, 2010, such disclosure controls and procedures were effective.

Disclosure controls and procedures are controls and other
procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SECs rules and
forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated
to management, including our Chief Executive Officer and Chief Financial Officer, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Managements Annual Report on Internal Control over Financial Reporting

The Companys management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rue 13a-15(f) under the Exchange Act). Internal control over
financial reporting is a process, including policies and procedures, designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance
with U.S. generally accepted accounting principles. Our management assessed our internal control over financial reporting based on the Internal Control  Integrated Framework issued by the COSO. Based on the results of this assessment,
our management concluded that our internal control over financial reporting were not effective as of December 31, 2010 based on such criteria due to the Companys lack of internal resources and lack of ability to have multiple levels of
transaction review. Through the use of external consultants and the review and audit process, management believes that the financial statements and other information presented herewith are materially correct.

Limitations on the Effectiveness of Controls

Our disclosure controls and procedures are designed to provide reasonable, not absolute, assurance that the objectives of our disclosure control system are met. Because of inherent limitations in all
control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within a company have been detected. Based on their evaluationas of the end of the period covered by this report, management
concluded that our disclosure controls and procedures were not effective to provide reasonable assurance that the objectives of our disclosure control system were met.

Changes in Internal Control over Financial Reporting

There were no changes in our
internal control over financial reporting that occurred during the fourth fiscal quarter ended December 31, 2010 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Auditors Report on Internal Control over Financial Reporting

This Annual Report does not include an attestation report of the Companys independent registered public accounting firm regarding internal control over financial reporting. Managements report
was not subject to attestation by the Companys registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission that permit the Company to provide only managements report in this Annual Report.



12



---

##### Table of Contents

|Item 9B. | OTHER INFORMATION.
|-------- | ------------------

None



|Item 10. | DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS, CONTROL PERSONS AND CORPORATE GOVERNANCE; COMPLIANCE WITH SECTION 16(A) OF THE EXCHANGE ACT.
|-------- | --------------------------------------------------------------------------------------------------------------------------------------

The following are the names and certain information regarding the current Directors and Executive Officers of the Company:



|                   |  |     |  |                                                       |  |                |      | 
|------------------ |  | --- |  | ----------------------------------------------------- |  | -------------- | ---- | 
|Name               |  | Age |  | Position                                              |  | Director Since |     
|Stephen M. Watters |  | 43  |  | Chief Executive and Chief Financial Officer, Director |  |                | 2006 | 
|                   |  |     | 
|Jugal K. Taneja    |  | 66  |  | Director                                              |  |                | 2000 | 
|                   |  |     | 
|Alfred Lehmkuhl    |  | 78  |  | Director                                              |  |                | 2002 | 

Pursuant to the
Companys bylaws, each director serves for a term of one year and until his successor is duly qualified. Officers are elected annually by the Board of Directors (subject to the terms of any employment agreement), at the Companys annual
meeting, to hold such office until an officers successor has been duly appointed and qualified, unless an officer sooner dies, resigns or is removed by the Board. Some of the directors and executive officers of the Company also serve in
various capacities with subsidiary of the Company. There are no family relationships among any of the Companys other directors and executive officers.

Background of Executive Officers and Directors

On January 4, 2006
Stephen Watters resigned as Chief Executive Officer of the Company and effective July 7, 2006, was reappointed Chief Executive and Financial Officer of the Company. Prior to working with us, Mr. Watters was the Co-founder, Chief Executive
Officer and President, of DrugMax, Inc., from September 1998 until August 2000. DrugMax, was a wholesaler and retailer of pharmaceuticals, over-the counter drugs, health and beauty care products and private label dietary supplements. DrugMax was
subsequently renamed FamilyMed and is no longer in business. From September through November 1998, Mr. Watters served as Vice President of Finance of Dynamic Health Products, Inc., a publicly-held nutraceutical products company. Prior to that,
he worked in the investment banking and brokerage businesses from April 1992 to September 1998. He received his Executive Masters of Business Administration degree from Case Western Reserve University in 1997.

On January 4, 2006, Jugal Taneja resigned as a consultant to the Company. Jugal K. Taneja had served as a director of the Company
since its inception and as a consultant to the Company since March 2000. In addition to his service to the Company, Mr. Taneja operates several other companies. He served as Co-Chairman of the Board of DrugMax, Inc., and from October 2000 to
November 2004 served as DrugMaxs Chief Executive Officer. He previously served as DrugMaxs Chief Executive Officer from its inception in October 1993 through April 1995, and again from January 1996 until August 1999. Further, he served
at various times over the years as DrugMaxs President and Secretary. DrugMax was a wholesaler and retailer of pharmaceuticals, over-the counter drugs, health and beauty care products and private label dietary supplements. DrugMax was
subsequently named FamilyMed and is no longer in business. Mr. Taneja also serves as Chairman and a director of Geopharma, Inc., a publicly-held pharmaceutical and nutraceutical products company. Mr. Taneja holds degrees in Petroleum
Engineering, Mechanical Engineering, and a Masters in Business Administration from Rutgers University.

Alfred F. Lehmkuhl has
been a Director since May 2002. Since June 1988, he has been Chief Executive Officer of Seven Limers, Inc., an agricultural equipment and supply company, and KAS Trucking, Inc., a regulated



13



---

##### Table of Contents

common carrier trucking company. He served as President and Chief Executive Officer of Horns Crop Service, Inc., an agricultural supply company from September 1984 to December 1993.
Mr. Lehmkuhl holds a Bachelor of Science degree in Animal Nutrition from The Ohio State University.

Section 16(a) Beneficial
Ownership Reporting Compliance

Based solely upon a review of Forms 3, 4, 5, and amendments thereto, furnished to the
Company during fiscal year 2009 and 2010, the Company is not aware of any director, officer or beneficial owner of more than ten percent of the Companys Common Stock that failed to file reports required by Section 16(a) of the Securities
Exchange Act of 1934 on a timely basis during fiscal year 2010.

Code of Ethics

The Company has adopted its Code of Ethics and Business Conduct for Officers, Directors and Employees, which applies to all of the
officers, directors and employees of the Company. The Code of Ethics is filed as an exhibit to this Report on Form 10-K, incorporated by reference.

Audit Committee Financial Expert.

The Board of Directors acts as the
Companys audit committee.

Changes in Nominating Procedures.

None.



|Item 11. | EXECUTIVE COMPENSATION
|-------- | ----------------------

SUMMARY COMPENSATION TABLE (1)



|                             |  |                            |  |           |   |  |          |  |   |                |  |  |                      |  |  |                          |   |  |          |   |        |  |  |   |        | 
|---------------------------- |  | -------------------------- |  | --------- | - |  | -------- |  | - | -------------- |  |  | -------------------- |  |  | ------------------------ | - |  | -------- | - | ------ |  |  | - | ------ | 
|                             |  | Summary Compensation Table |  |           |   |  |          |  |  
|Name Principal Positions     |  | YearEnded                  |  | Salary($) |   |  | Bonus($) |  |   | StockAwards($) |  |  | OptionAwards($) 
(A) |  |  | All OtherCompensation($) |   |  | Total($) |  
|Stephen M. Watters, CEO, CFO |  | 2010                       |  |           | 0 |  |          |  |  |                |  |  |                     |  |  |                          |  |  |          | $ | 12,000 |  |  | $ | 12,000 | 
|                             |  | 2009                       |  |           | 0 |  |          |  |  |                |  |  |                     |  |  |                          |  |  |          | $ | 12,000 |  |  | $ | 12,000 | 
|                             |  | 2008                       |  |           | 0 |  |          |  |  |                |  |  |                     |  |  |                          |  |  |          |   |       |  |  |   | 0      | 

During the year ended
December 31, 2010, the Company did not pay any director fees for each meeting attended by such director. Directors who are also employees receive no compensation for serving on the Board. The Companys non-employee directors receive
options to purchase shares of common stock at the market price on the date they are granted, reimbursement of expenses incurred consequential to their service and may receive additional options at the discretion of the Board. There was no
compensation paid to our non-employee directors during the year ended December 31, 2010.

Employment Agreements

The Company did not have any outstanding employment contracts with any of its officers or directors for the year ended December 31, 2010.

The Company did not grant or issue any stock options for the year ended December 31, 2010.



14



---

##### Table of Contents

|                                          |  |           |  |  |                                                            |  |   |                                                                 |  |  |                                                 |  |  |                                              |   |  |  |  |   | 
|----------------------------------------- |  | --------- |  |  | ---------------------------------------------------------- |  | - | --------------------------------------------------------------- |  |  | ----------------------------------------------- |  |  | -------------------------------------------- | - |  |  |  | - | 
|Name                                      |  | GrantDate |  |  | All OtherStock Awards:Number ofShares of StockOr Units
(#) |  |   | All OtherOption Awards:Number ofSecuritiesUnderLyingOptions
(#) |  |  | Exercise orBase PriceOf OptionAwards($ / Share) |  |  | Grant DateFair ValueOf Stock andOptionAwards |  
|Stephen M. Watters, CEO, CFO and Director |  |           |  |  |                                                            |  |  |                                                                 |  |  |                                                |  |  |                                              |  |  |  |  |  | 



|Item 12. | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.
|-------- | -----------------------------------------------------------------------------------------------

The following table sets forth certain information, as of December 31, 2010 with respect to the beneficial ownership of the
outstanding Common Stock by (i) any holder of more than five (5%) percent; (ii) each of the Companys executive officer and directors; and (iii) the directors and executive officer of the Company as a group. An asterisk
indicates beneficial ownership of less than 1% of the outstanding Common Stock. Except as otherwise indicated, each of the shareholders listed below has sole voting and investment power over the shares beneficially owned.



|       |  |                                                   |  |                                           |            |  |                                    |  |       |  
|------ |  | ------------------------------------------------- |  | ----------------------------------------- | ---------- |  | ---------------------------------- |  | ----- | -
|Class  |  | Name and Address of Beneficial Owner(1)           |  | Amount andNature ofBeneficialOwnership(2) |            |  | ApproximateTitle ofPercent OfClass | 
|Common |  | Stephen M. Watters(3)                             |  |                                           | 19,162,244 |  |                                    |  | 43.09 | %
|Common |  | Brian T. Nugent (4)                               |  |                                           | 5,427,085  |  |                                    |  | 12.20 | %
|Common |  | Jugal K. Taneja(5)                                |  |                                           | 13,997,603 |  |                                    |  | 31.47 | %
|       |  |                                                   | 
|Common |  | Alfred Lehmkuhl(6)                                |  |                                           | 1,562,395  |  |                                    |  | 3.51  | %
|Common |  | All officers and directors as a group (3 persons) |  |                                           | 34,722,242 |  |                                    |  | 78.07 | %



|(1) | Except as otherwise indicated, the address of each beneficial owner is c/o Vertical Health Solutions, Inc. at 180 Douglas Ave., East, Oldsmar, FL 34677.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------

|(2) | Beneficial ownership is determined in accordance with the rules of the Commission and generally includes voting or investment power with respect to the shares shown.
Except where indicated by footnote and subject to community property laws where applicable, the persons named in the table have sole voting and investment power with respect to all shares of voting securities shown as beneficially owned by them.
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(3) | Of the shares beneficially owned by Mr. Watters, 1,913,868 shares are owned by SMW Capital Group Limited Partnership, a company owned and controlled by
Mr. Watters. Also includes 228,575 shares are owned by Kristen Watters, Mr. Watters wife. Mr. Watters disclaims beneficial ownership of the shares registered in the name of his wife.
|--- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(4) | Of the shares beneficially owned by Mr. Nugent, 95,240 shares are owned by Julie Nugent, Mr. Nugents wife. Mr. Nugent disclaims beneficial
ownership of the shares registered in the name of his wife.
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(5) | Of the shares beneficially owned by Mr. Taneja, 450,994 shares are owned by Manju Taneja, Mr. Tanejas wife. 839,570 shares are owned by Carnegie Capital
LLC, a company owned and controlled by Mr. Taneja, and 322,232 shares are owned by Bryan Capital Limited Partnership, a company wholly-owned by Dynamic Health Products, Inc., a public company which is controlled by Mr. Taneja.
Mr. Taneja disclaims beneficial ownership of the shares registered in the name of his wife.
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(6) | Of the shares beneficially owned by Mr. Lehmkuhl, 38,100 shares are held by Mr. Lehmkuhl as custodian for each of Joseph J. Zam, Jr. and Katelyn C. Zam,
Mr. Lehmkuhls grandchildren.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



15



---

##### Table of Contents

|Item 13. | CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE.
|-------- | -------------------------------------------------------------------------

The Company had a verbal agreement with Vitality Systems, Inc., a related party, to pay expenses on their behalf. Jugal Taneja, Brian Nugent and Steve Watters are all shareholders of both Vitality
Systems, Inc. and the Company. The agreement had no specific repayment terms and was non-interest bearing. As of December 31, 2010 and 2009, the Company owed the related party $10,370 and $0, respectively.

As of December 31, 2010 and 2009, the Company had an outstanding obligation to Steve Watters, Chief Executive and Financial Officer,
in the amount of $21,000 and $12,000, respectively, for services rendered and payment of invoices on the Companys behalf.

The Company believes that material affiliated transactions and loans, and business relationships entered into by the Company with certain
of its officers, directors and principal shareholders or their affiliates were on terms no less favorable than the Company could have obtained from independent third parties. Any future transactions between the Company and its officers, directors or
affiliates will be subject to approval by a majority of disinterested directors or shareholders in accordance with Florida law.

Director Independence.

Alfred Lehmkuhl is an independent director.



|Item 14. | PRINCIPAL ACCOUNTING FEES AND SERVICES.
|-------- | ---------------------------------------

Audit Fees. The aggregate fees billed by our auditors to date, for professional services rendered for the audit of the Companys annual financial
statements for the years ended December 31, 2010 and 2009, and for review of the financial statements included in the Companys quarterly reports on Form 10-Q during such fiscal years, were $24,000 and $24,000, respectively.

Tax Fees. The aggregate fees billed for tax preparation and related services by our auditors was $0 for the years ended December 31, 2010 and 2009.

All Other Fees. For the fiscal year ended December 31, 2010 and 2009, the Company incurred fees to auditors of $0 for services rendered
to the Company, other than the services covered in Audit Fees, Audit-Related Fees or Tax Fees.



|Item 15. | EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.
|-------- | -------------------------------------------

The following exhibits are filed with this report:



3.1

Amended and Restated Articles of Incorporation*3.2

Amendment Creating Class of Preferred Stock*3.3

By-Laws*3.4

Certificate of Incorporation of Vertical Health Ventures, Inc., a wholly-owned subsidiary of the Company, filed as Exhibit 3.4 to Form SB-2, File No. 333-116682.3.5

Certificate of Designation of Vertical Health Ventures, Inc., designating the rights of Series A Cumulative Convertible Preferred Stock, as amended, filed as Exhibit 3.5 to Form
SB-2, File No. 333-116682.




16



---

##### Table of Contents

3.6

Bylaws of Vertical Health Ventures, Inc, filed as Exhibit 3.6 to Form SB-2, File No. 333-116682.4.1

Specimen Stock Certificate*4.2

Amendment No. 1 to Securities Purchase Agreement, dated as of September 20, 2004, filed as exhibit 4.9 to Companys Report on Form SB2/A dated as of October 20, 2004, and
incorporated herein by reference.10.1

Form of 2001 Stock Option Plan*10.2

Agreement and Plan of Merger, dated February 1, 2011, by and among OnPoint Medical Diagnostics, Inc., Vertical Health Solutions, Inc. and Vertical HS Acquisition
Corp.**14.1

Code of Ethics of Vertical Health Solutions, Inc.***31.1

Certification Of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.32.1

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.




|* | Incorporated by reference to the Companys registration statement on Form SB-2, file no. 333-74766.
|- | ---------------------------------------------------------------------------------------------------

|** | Incorporated by reference to the Companys Current Report on Form 8-K, filed on February 7, 2010.
|-- | -------------------------------------------------------------------------------------------------

|*** | Incorporated by reference to the Companys 10-KSB filed for the year ending December 31, 2007.
|--- | ----------------------------------------------------------------------------------------------



17



---

##### Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.



|                      |  |  |  |     |  |                                                                        
|--------------------- |  |  |  | --- |  | -----------------------------------------------------------------------
|                      |  |  |  |     |  | VERTICAL HEALTH SOLUTIONS, INC.                                        
|                      |  |  | 
|Dated: March 16, 2011 |  |  |  | By: |  | /s/ Stephen M. Watters                                                 
|                      |  |  |  |     |  | Stephen M. Watters, Chief Executive Officer and Chief Financial Officer

Pursuant to the
requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.



|          |  |                        |  |          |  |               
|--------- |  | ---------------------- |  | -------- |  | --------------
|Signature |  | Title                  |  | Date    
|          |  |                        | 
|By:       |  | /s/ Stephen M. Watters |  | Director |  | March 16, 2011
|          |  | Stephen M. Watters     |  |          |  |               
|          |  |                        | 
|By:       |  | /s/ Jugal K. Taneja    |  | Director |  | March 16, 2011
|          |  | Jugal K. Taneja        |  |          |  |               
|          |  |                        | 
|By:       |  | /s/ Alfred Lehmkuhl    |  | Director |  | March 16, 2011
|          |  | Alfred Lehmkuhl        |  |          |  |               



18



---

##### Table of Contents

VERTICAL HEALTH SOLUTIONS, INC.

INDEX TO FINANCIAL STATEMENTS AND SCHEDULES



|                                                                                              |  |           
|--------------------------------------------------------------------------------------------- |  | ----------
|                                                                                              |  | PAGE      
|                                                                                              | 
|Report of Independent Registered Public Accounting Firm                                       |  | F-2       
|                                                                                              | 
|Balance Sheets as of December 31, 2010 and 2009                                               |  | F-3       
|                                                                                              | 
|Statements of Operations for the years ended December 31, 2010 and 2009                       |  | F-4       
|                                                                                              | 
|Statements of Changes in Stockholders Equity for the years ended December 
31, 2010 and 2009 |  | F-5       
|                                                                                              | 
|Statements of Cash Flows for the years ended December 31, 2010 and 2009                       |  | F-6  F-7 
|                                                                                              | 
|Notes to Financial Statements                                                                 |  | F-8  F-13



---

##### Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Board of Directors

Vertical Health Solutions,
Inc.

We have audited the accompanying balance sheets of Vertical Health Solutions, Inc. as of December 31, 2010 and 2009, and the
related statements of operations, changes in shareholders equity, and cash flows for the years then ended. Vertical Health Solution, Inc.s management is responsible for these financial statements. Our responsibility is to express an
opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor
were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances,
but not for the purpose of expressing an opinion on the effectiveness of the Companys internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the
amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the
financial position of Vertical Health Solutions, Inc. as of December 31, 2010 and 2009 and the results of operations and cash flows for the years ended December 31, 2010 and 2009 in conformity with accounting principles generally accepted
in the United States of America.

The accompanying financial statements have been prepared assuming that the Company will continue as a going
concern. As discussed in Note 2 to the financial statements, the Company incurred a net loss of $80,576 during the year ended December 31, 2010, and, as of that date, had a working capital deficiency of $197,012 and a retained deficit of
$3,013,340. The Company currently has no revenue producing activities and there are no assurances that they will be able to obtain additional financing, if required. These conditions raise substantial doubt about the Companys ability to
continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ BRIMMER, BUREK & KEELAN LLP

Brimmer, Burek & Keelan LLP

Tampa,
Florida

March 11, 2011



F-2



---

##### Table of Contents

VERTICAL HEALTH SOLUTIONS, INC.

BALANCE SHEETS

December 31,



|                                                                                                       |  |      |            |   |      |   |            |  
|------------------------------------------------------------------------------------------------------ |  | ---- | ---------- | - | ---- | - | ---------- | -
|                                                                                                       |  | 2010 |            |   | 2009 |  
|Assets                                                                                                 |  |      |            |   |      |   |            |  
|Cash                                                                                                   |  | $    | 4,856      |   |      | $ | 2,932      |  
|Deposits                                                                                               |  |      |           |   |      |   | 1,800      |  
|                                                                                                       |  |      |            |   |      |   |            |  
|Total current assets                                                                                   |  |      | 4,856      |   |      |   | 4,732      |  
|                                                                                                       |  |      |            |   |      |   |            |  
|Total Assets                                                                                           |  | $    | 4,856      |   |      | $ | 4,732      |  
|                                                                                                       |  |      |            |   |      |   |            |  
|                                                                                                       |  |     
|Liabilities and Stockholders Equity (Deficit)                                                         |  |      |            |   |      |   |            |  
|Current liabilities:                                                                                   |  |      |            |   |      |   |            |  
|Accounts payable                                                                                       |  | $    | 34,901     |   |      | $ | 9,168      |  
|Accrued expenses, related parties                                                                      |  |      | 41,967     |   |      |   | 12,000     |  
|Notes payable                                                                                          |  |      | 125,000    |   |      |   | 100,000    |  
|Notes payable to related parties                                                                       |  |      |           |   |      |   |           |  
|                                                                                                       |  |      |            |   |      |   |            |  
|                                                                                                       |  |     
|Total current liabilities                                                                              |  |      | 201,868    |   |      |   | 121,168    |  
|                                                                                                       |  |      |            |   |      |   |            |  
|                                                                                                       |  |     
|Total liabilities                                                                                      |  |      | 201,868    |   |      |   | 121,168    |  
|                                                                                                       |  |      |            |   |      |   |            |  
|                                                                                                       |  |     
|Commitments and contingencies                                                                          |  |      |           |   |      |   |           |  
|                                                                                                       |  |     
|Stockholders equity (deficit):                                                                        |  |      |            |   |      |   |            |  
|                                                                                                       |  |     
|Preferred stock, $0.001 par value, 5,000,000 shares authorized:                                        |  |      |            |   |      |   |            |  
|Series A; 10% cumulative, convertible; 1,000,000 shares authorized, no shares issued and outstanding   |  |      |           |   |      |   |           |  
|Undesignated, 4,000,000 shares authorized, no shares issued and outstanding                            |  |      |           |   |      |   |           |  
|Common stock, $.001 par value, 250,000,000 shares authorized; 44,474,973 shares issued and outstanding |  |      | 44,476     |   |      |   | 44,476     |  
|Additional paid-in capital                                                                             |  |      | 2,771,852  |   |      |   | 2,771,852  |  
|Accumulated deficit                                                                                    |  |      | (3,013,340 | ) |      |   | (2,932,764 | )
|                                                                                                       |  |      |            |   |      |   |            |  
|                                                                                                       |  |     
|Total stockholders deficit                                                                            |  |      | (197,012   | ) |      |   | (116,436   | )
|                                                                                                       |  |      |            |   |      |   |            |  
|                                                                                                       |  |     
|                                                                                                       |  | $    | 4,856      |   |      | $ | 4,732      |  
|                                                                                                       |  |      |            |   |      |   |            |  

See accompanying notes to financial statements.



F-3



---

##### Table of Contents

VERTICAL HEALTH SOLUTIONS, INC.

STATEMENTS OF OPERATIONS

Years Ended December 31, 2010 and 2009



|                                                                       |  |      |            |   |      |   |            |  
|---------------------------------------------------------------------- |  | ---- | ---------- | - | ---- | - | ---------- | -
|                                                                       |  | 2010 |            |   | 2009 |  
|                                                                       |  |     
|Sales                                                                  |  | $    |           |   |      | $ |           |  
|Cost of goods sold                                                     |  |      |           |   |      |   |           |  
|                                                                       |  |      |            |   |      |   |            |  
|Gross profit                                                           |  |      |           |   |      |   |           |  
|                                                                       |  |      |            |   |      |   |            |  
|Operating expenses:                                                    |  |      |            |   |      |   |            |  
|Selling, general and administrative expenses                           |  |      | 80,576     |   |      |   | 56,641     |  
|                                                                       |  |      |            |   |      |   |            |  
|Total operating expenses                                               |  |      | 80,576     |   |      |   | 56,641     |  
|                                                                       |  |      |            |   |      |   |            |  
|                                                                       |  |     
|Operating loss before other income and expense                         |  |      | (80,576    | ) |      |   | (56,641    | )
|                                                                       |  |      |            |   |      |   |            |  
|Other income (expense):                                                |  |      |            |   |      |   |            |  
|Gain on settlement of liability                                        |  |      |           |   |      |   |           |  
|                                                                       |  |      |            |   |      |   |            |  
|Total other income (expense)                                           |  |      |           |   |      |   |           |  
|                                                                       |  |      |            |   |      |   |            |  
|Loss before income taxes                                               |  |      | (80,576    | ) |      |   | (56,641    | )
|                                                                       |  |      |            |   |      |   |            |  
|Income taxes                                                           |  |      |           |   |      |   |           |  
|                                                                       |  |      |            |   |      |   |            |  
|Net loss available to common stockholders                              |  | $    | (80,576    | ) |      | $ | (56,641    | )
|                                                                       |  |      |            |   |      |   |            |  
|Basic and diluted loss per share from continuing operations            |  | $    | (0.00      | ) |      | $ | (0.00      | )
|                                                                       |  |      |            |   |      |   |            |  
|Basic and diluted weighted average number of common shares outstanding |  |      | 44,474,973 |   |      |   | 44,474,973 |  
|                                                                       |  |      |            |   |      |   |            |  

See accompanying notes to financial statements.



F-4



---

##### Table of Contents

VERTICAL HEALTH SOLUTIONS, INC.

STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY DEFICIT

Years Ended December 31, 2010 and 2009



|                             |  |                 |   |  |              |   |   |                          |  |  |                    |  |  |                           |        |  |  |   |           |  |  |   |            |   |  |   |          |  
|---------------------------- |  | --------------- | - |  | ------------ | - | - | ------------------------ |  |  | ------------------ |  |  | ------------------------- | ------ |  |  | - | --------- |  |  | - | ---------- | - |  | - | -------- | -
|                             |  | Preferred Stock |   |  | Common Stock |   |   | AdditionalPaid-inCapital |  |  | AccumulatedDeficit |  |  | TotalStockholdersDeficit |       
|                             |  | Shares          |   |  | Dollars      |   |   | Shares                   |  |  | Dollars            |  |  |                           |       
|Balance at December 31, 2008 |  |                 | 0 |  |              | $ | 0 |                          |  |  | 44,474,973         |  |  | $                         | 44,476 |  |  | $ | 2,771,852 |  |  | $ | (2,876,123 | ) |  | $ | (59,795  | )
|Net loss                     |  |                 |   |  |              |   |   |                          |  |  |                    |  |  |                           |        |  |  |   |           |  |  |   | (56,641    | ) |  |   | (56,641  | )
|                             |  |                 |   |  |              |   |   |                          |  |  |                    |  |  |                           |        |  |  |   |           |  |  |   |            |   |  |   |          |  
|Balance, December 31, 2009   |  |                 | 0 |  |              | $ | 0 |                          |  |  | 44,474,973         |  |  |                           | 44,476 |  |  |   | 2,771,852 |  |  |   | (2,932,764 | ) |  |   | (116,436 | )
|Net loss                     |  |                 |   |  |              |   |   |                          |  |  |                    |  |  |                           |        |  |  |   |           |  |  |   | (80,576    | ) |  |   | (80,576  | )
|                             |  |                 |   |  |              |   |   |                          |  |  |                    |  |  |                           |        |  |  |   |           |  |  |   |            |   |  |   |          |  
|Balance, December 31, 2010   |  |                 | 0 |  |              | $ | 0 |                          |  |  | 44,474,973         |  |  | $                         | 44,476 |  |  | $ | 2,771,852 |  |  | $ | (3,013,340 | ) |  | $ | (197,012 | )
|                             |  |                 |   |  |              |   |   |                          |  |  |                    |  |  |                           |        |  |  |   |           |  |  |   |            |   |  |   |          |  

See accompanying notes to financial statements.



F-5



---

##### Table of Contents

VERTICAL HEALTH SOLUTIONS, INC.

STATEMENTS OF CASH FLOWS

Years Ended December 31, 2010 and 2009



|                                                                                |  |      |         |   |      |   |         |  
|------------------------------------------------------------------------------- |  | ---- | ------- | - | ---- | - | ------- | -
|                                                                                |  | 2010 |         |   | 2009 |  
|Cash flows from operating activities:                                           |  |      |         |   |      |   |         |  
|Net loss                                                                        |  | $    | (80,576 | ) |      | $ | (56,641 | )
|Adjustments to reconcile net loss to net cash provided by operating activities: |  |      |         |   |      |   |         |  
|Changes in operating assets and liabilities:                                    |  |      |         |   |      |   |         |  
|Deposits                                                                        |  |      | 1,800   |   |      |   |        |  
|Accounts payable                                                                |  |      | 25,733  |   |      |   | (45,135 | )
|Accrued expenses                                                                |  |      | 14,597  |   |      |   | 10,800  |  
|                                                                                |  |      |         |   |      |   |         |  
|Net cash used by operating activities                                           |  |      | (38,446 | ) |      |   | (90,976 | )
|                                                                                |  |      |         |   |      |   |         |  
|                                                                                |  |     
|Cash flows from investing activities                                            |  |      |        |   |      |   |        |  
|                                                                                |  |     
|Cash flows from financing activities:                                           |  |      |         |   |      |   |         |  
|Proceeds from notes payable                                                     |  |      | 25,000  |   |      |   | 100,000 |  
|Proceeds (payments) from related party notes payable                            |  |      | 15,370  |   |      |   | (6,092  | )
|                                                                                |  |      |         |   |      |   |         |  
|Net cash provided by financing activities                                       |  |      | 40,370  |   |      |   | 93,908  |  
|                                                                                |  |      |         |   |      |   |         |  
|                                                                                |  |     
|Net increase in cash                                                            |  |      | 1,924   |   |      |   | 2,932   |  
|Cash at beginning of period                                                     |  |      | 2,932   |   |      |   |        |  
|                                                                                |  |      |         |   |      |   |         |  
|                                                                                |  |     
|Cash at end of period                                                           |  | $    | 4,856   |   |      | $ | 2,932   |  
|                                                                                |  |      |         |   |      |   |         |  

See accompanying notes to financial statements.



F-6



---

##### Table of Contents

VERTICAL HEALTH SOLUTIONS, INC.

STATEMENTS OF CASH FLOWSContinued

Years Ended December 31, 2010 and 2009



|                                                  |  |      |   |  |      |   |   | 
|------------------------------------------------- |  | ---- | - |  | ---- | - | - | 
|                                                  |  | 2010 |   |  | 2009 |  
|Supplemental disclosure of cash flow information: |  |      |   |  |      |   |   | 
|Cash paid during the period for interest          |  | $    |  |  |      | $ |  | 
|Cash paid during the period for income taxes      |  | $    |  |  |      | $ |  | 

See accompanying notes
to financial statements.



F-7



---

##### Table of Contents

VERTICAL HEALTH SOLUTIONS, INC.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2010 AND 2009

NOTE 1  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Vertical Health Solutions, Inc., incorporated as Labelclick.com, Inc. on March 3, 2000 under the laws of the State of
Florida, is located in Oldsmar, Florida. The Company changed its name to Vertical Health Solutions, Inc. on January 11, 2001.

Cash
and Cash Equivalents

For purposes of the statement of cash flows, the Company considers all highly liquid instruments
purchased with a maturity of three months or less to be cash equivalents.

Impairment of Assets

The Companys policy is to evaluate whether there has been a permanent impairment in the value of long-lived assets, certain
identifiable intangibles and goodwill when certain events have taken place that indicate that the remaining balance may not be recoverable. When factors indicate that the intangible assets should be evaluated for possible impairment, the Company
uses an estimate of related undiscounted cash flows. A deficiency in these cash flows relative to the carrying amounts is an indication of the need for a write-down due to impairment. The impairment write-down would be the difference between the
carrying amounts and the fair value of these assets. Losses on impairment are recognized by a charge to earnings. Factors considered in the valuation include current operating results, trends and anticipated undiscounted future cash flows. There
were no impairment losses recorded during the years ended December 31, 2010 and 2009.

Income Taxes

Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes
resulting from temporary differences. Such temporary differences result from differences in the carrying value of assets and liabilities for tax and financial reporting purposes. The deferred tax assets and liabilities represent the future tax
consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be
realized.

The Company adopted the provisions of FASB ASC 740-10 Uncertainty in Income Taxes (ASC 740-10), on
January 1, 2007. The Company has not recognized a liability as a result of the implementation of ASC 740-10. A reconciliation of the beginning and ending amount of unrecognized tax benefits has not been provided since there is no unrecognized
benefit since the date of adoption. The Company has not recognized interest expense or penalties as a result of the implementation of ASC 740-10. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to
unrecognized tax benefits in interest expense and penalties in operating expenses.

Earnings (Loss) Per Common Share

Earnings (loss) per share are computed using the basic and diluted calculations on the face of the statement of operations. Basic earnings
(loss) per share are calculated by dividing net income by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income by the weighted average number of
shares of common stock outstanding for the period, adjusted for the dilutive effect of common stock equivalents, using the treasury stock method.

Use of Estimates

The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at
December 31, 2010 and 2009, as well as the reported amounts of revenues and expenses for the years then ended. The actual outcome of the estimates could differ from the estimates made in the preparation of the financial statements.



F-8



---

##### Table of Contents

Revenue Recognition

Revenues are recognized when the merchandise is shipped and title passes to the customer. Revenue is recorded net of any discounts, allowances, returns or credits. Returns are allowed for certain products
and are subject to a restocking fee. The Company has not experienced any significant discounts, allowances, returns or credits to date as the Company has not had any revenue since the year ended December 31, 2007.

Stock Based Compensation

The Company
recognizes all share-based payments to employees, including grants of employee stock options, as compensation expense in the financial statements based on their fair values. That expense will be recognized over the period during which an employee is
required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

The basis for the
above assumptions are as follows: the dividend rate is based upon the Companys history of dividends; the risk-free interest rate for periods within the expected term of the option is based on the U.S. Treasury yield curve in effect at the
time of grant; the expected term was calculated based on the Companys historical pattern of options granted and the period of time they are expected to be outstanding; and expected volatility was calculated by review of a peer companys
historical activity.

As of December 31, 2010 and 2009, the Company has not awarded any share-based payments.

Non-Employee Stock-Based Compensation The Company accounts for stock based compensation awards issued to non-employees for services and
financing arrangements, as prescribed by FASB ASC 505-50, Equity-Based Payments to Non-Employees, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily
determinable. The fair value of common stock issued for services is based on the closing stock price on the date the common stock was issued.

As of December 31, 2010 and 2009, the Company has not awarded any stock based compensation.

Advertising Costs

The
Company charges advertising costs to expense as incurred. Advertising expense was $0 for each of the years ended December 31, 2010 and 2009.

Fair Value of Financial Instruments

The Company, in estimating its fair
value disclosures for financial instruments, uses the following methods and assumptions:

Deposits, Accounts Payable and
Accrued Expenses: The carrying amounts reported in the balance sheet for deposits, accounts payable and accrued expenses approximate their fair value due to their relatively short maturity.

Earnings (Loss) Per Share

Earnings (loss) per share are computed using the basic and diluted calculations on the face of the statement of operations. Basic earnings
(loss) per share are calculated by dividing net income (loss) available to common shareholders by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share is calculated by dividing the net
income (loss) by the weighted average number of shares of common stock outstanding for the period, adjusted for the dilutive effect of common stock equivalents, using the treasury stock method.



F-9



---

##### Table of Contents

The following sets forth the computation of basic and diluted net earnings (loss) per common
share for years ended December 31, 2010 and 2009:



|                                                     |  |                   |            |   |                   |   |            |  
|---------------------------------------------------- |  | ----------------- | ---------- | - | ----------------- | - | ---------- | -
|                                                     |  | December 31, 2010 |            |   | December 31, 2009 |  
|Numerator:                                           |  |                   |            |   |                   |   |            |  
|Net loss                                             |  | $                 | (80,576    | ) |                   | $ | (56,641    | )
|Less preferred stock dividend and accreted dividends |  |                   |           |   |                   |   |           |  
|                                                     |  |                   |            |   |                   |   |            |  
|Net loss available to common stockholders            |  | $                 | (80,576    | ) |                   | $ | (56,641    | )
|                                                     |  |                   |            |   |                   |   |            |  
|Denominator:                                         |  |                   |            |   |                   |   |            |  
|Weighted average basic shares outstanding            |  |                   | 44,474,973 |   |                   |   | 44,474,973 |  
|Stock options                                        |  |                   |           |   |                   |   |           |  
|                                                     |  |                   |            |   |                   |   |            |  
|Warrants                                             |  |                   |           |   |                   |   |           |  
|                                                     |  |                   |            |   |                   |   |            |  
|Weighted average fully diluted shares outstanding    |  |                   | 44,474,973 |   |                   |   | 44,474,973 |  
|                                                     |  |                   |            |   |                   |   |            |  
|Net loss per common shareBasic and diluted          |  | $                 | (0.00      | ) |                   | $ | (0.00      | )
|                                                     |  |                   |            |   |                   |   |            |  

NOTE 2 GOING CONCERN

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates continuation of Vertical Health
Solutions, Inc. (VHS) as a going concern. However, VHS has sustained operating losses in recent years and following the sale of Drug Depot has no operating revenue. Further for the year ended December 31, 2010, VHS had negative working capital
of $197,012. The Company has incurred losses in previous years resulting in an accumulated deficit of approximately $3,013,340. These factors raise substantial doubt about the ability of Vertical Health Solutions, Inc. to continue as a going
concern.

The Company is pursuing the further growth of the business through mergers and acquisitions, as noted in Note 8.
Failure to secure a merger or acquisition, secure equity financing or to raise additional capital may result in the Company depleting its available funds and not being able to pay its obligations.

The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification
of assets of the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

NOTE 3 RELATED PARTY TRANSACTIONS

The Company had a verbal agreement with Vitality
Systems, Inc., a related party, to pay expenses on their behalf. Jugal Taneja, Brian Nugent and Steve Watters are all shareholders of both Vitality Systems, Inc. and the Company. The agreement had no specific repayment terms and was non-interest
bearing. As of December 31, 2010 and 2009, the Company owed the related party $10,370 and $0, respectively.

As of December 31, 2010
and 2009, the Company had an outstanding obligation to Steve Watters, Chief Executive and Financial Officer, in the amount of $21,000 and $9,000, respectively, for services rendered and payment of invoices on the Companys behalf.

NOTE 4  INCOME TAXES

Income tax expense (benefit) for the years ended December 31, 2010 and 2009 is as follows:



|                                      |  |      |   |  |      |   |   | 
|------------------------------------- |  | ---- | - |  | ---- | - | - | 
|                                      |  | 2010 |   |  | 2009 |  
|Current income tax expense (benefit)  |  | $    |  |  |      | $ |  | 
|Deferred income tax expense (benefit) |  |      |  |  |      |   |  | 
|                                      |  |      |   |  |      |   |   | 
|Income tax expense (benefit)          |  | $    |  |  |      | $ |  | 
|                                      |  |      |   |  |      |   |   | 



F-10



---

##### Table of Contents

Income taxes for the years ended December 31, 2010 and 2009 differs from the amounts
computed by applying the effective income tax rate of 34% to income before income taxes as a result of the following:



|                                               |  |      |         |   |      |   |         |  
|---------------------------------------------- |  | ---- | ------- | - | ---- | - | ------- | -
|                                               |  | 2010 |         |   | 2009 |  
|Computed tax benefit at the statutory rate 34% |  | $    | (27,400 | ) |      | $ | (19,300 | )
|Increase (decrease) in taxes resulting from:   |  |      |         |   |      |   |         |  
|Increase in valuation reserve                  |  |      | 27,400  |   |      |   | 19,300  |  
|                                               |  |      |         |   |      |   |         |  
|                                               |  |     
|Current income tax expense (benefit)           |  | $    |        |   |      | $ |        |  
|                                               |  |      |         |   |      |   |         |  

Temporary differences that give rise to deferred tax assets and liabilities:



|                                |  |      |          |   |      |   |          |  
|------------------------------- |  | ---- | -------- | - | ---- | - | -------- | -
|                                |  | 2010 |          |   | 2009 |  
|Deferred tax assets:            |  |      |          |   |      |   |          |  
|Net operating loss carryforward |  | $    | 698,100  |   |      | $ | 670,700  |  
|Less valuation allowance        |  |      | (698,100 | ) |      |   | (670,700 | )
|                                |  |      |          |   |      |   |          |  
|                                |  |     
|Gross deferred tax asset        |  |      |         |   |      |   |         |  
|Gross deferred tax liability    |  |      |         |   |      |   |         |  
|                                |  |      |          |   |      |   |          |  
|                                |  |     
|Net deferred tax asset          |  | $    |         |   |      | $ |         |  
|                                |  |      |          |   |      |   |          |  

The Company has available at December 31, 2010, approximately $1,993,000 of unused operating loss
carryforwards that may be applied against future taxable income and that expire in various years from 2021 to 2028. The Company does not have a reasonable expectation of utilizing the tax benefit of the net operating loss carryforward and therefore
has provided a full valuation allowance against the deferred tax asset.

We conduct business domestically and, as a result,
file income tax returns in the U.S. federal jurisdiction and various state and local jurisdictions. In the normal course of business, we are subject to examination in U.S. federal jurisdiction, and generally in state jurisdictions. With few
exceptions, we are no longer subject to U.S. federal, state and local tax examinations for years before 2006.

NOTE 5  OPTIONS

During 2001, the Company adopted a stock option plan to be administered by the board of directors. Under the plan, the
exercise price of any options granted may not be less than 100% of the fair market value of the Companys common stock on the date of the grant (110% for holders of more than 10% of the total combined voting power of all classes of capital
stock then outstanding).

There were no warrants outstanding as of December 31, 2010 and 2009, respectively.



|                                               |  |                |   |  |                              |   |   |                |  |  |                              |  |  |   |   | 
|---------------------------------------------- |  | -------------- | - |  | ---------------------------- | - | - | -------------- |  |  | ---------------------------- |  |  | - | - | 
|                                               |  | 2010           |   |  | 2009                         |  
|                                               |  | NumberofShares |   |  | WeightedAverageExercisePrice |   |   | NumberofShares |  |  | WeightedAverageExercisePrice | 
|Outstanding at January 1,                      |  |                |  |  |                              | $ |  |                |  |  |                             |  |  | $ |  | 
|Granted                                        |  |                |  |  |                              |   |  |                |  |  |                             |  |  |   |  | 
|Exercised/exchanged                            |  |                |  |  |                              |   |  |                |  |  |                             |  |  |   |  | 
|Forfeited                                      |  |                |  |  |                              |   |  |                |  |  |                             |  |  |   |  | 
|                                               |  |                |   |  |                              |   |   |                |  |  |                              |  |  |   |   | 
|Outstanding at December 31,                    |  |                |  |  |                              | $ |  |                |  |  |                             |  |  |   |  | 
|                                               |  |                |   |  |                              |   |   |                |  |  |                              |  |  |   |   | 
|Options exercisable at December 31,            |  |                |  |  |                              | $ |  |                |  |  |                             |  |  |   |  | 
|                                               |  |                |   |  |                              |   |   |                |  |  |                              |  |  |   |   | 
|Weighted average fair value of options granted |  |                |   |  |                              | $ |  |                |  |  |                              |  |  | $ |  | 
|                                               |  |                |   |  |                              |   |   |                |  |  |                              |  |  |   |   | 



F-11



---

##### Table of Contents

NOTE 6  NOTE PAYABLE

On February 1, 2009, the Company received $100,000 in exchange for a nonrecourse note payable. The note is non-interest bearing, unsecured and due on demand. As of today, there have been no demands
for repayment.

NOTE 7  NOTE PAYABLE  RELATED PARTY

During the year ended December 31, 2010, the Company received $25,000 from the Chief Executive Officer for operating capital. The note bears 10% interest is unsecured and due on demand. The Company
has accrued $1,097 of accrued interest which is included in accrued expenses on the Balance Sheets at December 31, 2010.

NOTE 8
 SUBSEQUENT EVENT

The Company has evaluated subsequent events through March 14, 2011, the date on which this Form 10-K was
filed with the Securities and Exchange Commission.

On February 1, 2011, the Company entered into an Agreement and Plan of
Merger (the Merger Agreement), by and among OnPoint Medical Diagnostics, Inc., a Minnesota corporation (OnPoint), the Company and Vertical HS Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of VHS
(Merger Sub). Pursuant to the Merger Agreement, on the closing date of the merger, the Merger Sub will merge with and into OnPoint, which will be the surviving company and a wholly-owned subsidiary of the Company (the
Merger).

OnPoint was founded to commercialize Magnetic Resonance Imaging Quality Assurance software and
technologies developed by the Mayo Clinic. OnPoint is a development stage company leveraging technology and intelligent systems to assist the healthcare industry in delivering high quality medical images in a safe, consistent and efficient manner.
These technology and intelligent systems are delivered in a Software-as-a-Service (SaaS) model, deployed in the cloud and exceed the accreditation standards required by law. OnPoint believes its comprehensive software service detects gradual
degradation in image quality, saves time and money by improving consistency and reliability, and facilitates proactive preventative maintenance that minimizes unplanned downtime.

As a condition to the Merger Agreement, the Company must complete a reverse stock split of its outstanding shares of common stock on a
one-for-164 basis prior to closing of the Merger (the Reverse Stock Split), such that immediately prior to the Merger, the Company will have no more than 1,084,756 shares of common stock outstanding. As of the date of filing of this Form
10-K, the Reverse Stock Split has not been effectuated. Pursuant to the Merger Agreement, upon completion of the Merger, the Company will issue an aggregate of 7,143,113 post reverse split shares of the Companys common stock (the
Acquisition Shares) to the shareholders of OnPoint in exchange for 100% of the issued and outstanding capital stock of OnPoint. In addition, up to 2,803,847 post reverse split shares of the Companys common stock may be issued upon
conversion of outstanding OnPoint promissory notes (at an assumed conversion price of $0.65 per share), up to 264,250 post reverse split shares of the Companys common stock may be issued upon exercise of warrants currently issued to purchase
OnPoint common stock (at an exercise price of $1.00 per share), and up to 800,000 post reverse split shares of the Companys common stock may be issued upon exercise of options currently issued to purchase OnPoint common stock (at an exercise
price of $1.00 per share). Of the 7,143,113 post reverse split Acquisition Shares, 1,000,000 post reverse split shares will be placed in escrow. Such shares will be released to the OnPoint stockholders in the event the Company completes an aggregate
of $1,000,000 of equity financing on or before December 31, 2011. If such financing is not completed on or before December 31, 2011, the 1,000,000 post reverse split shares will be cancelled.

Upon consummation of the Reverse Stock Split, the holders of certain promissory notes and other Company obligations aggregating $150,000
(the VHS Promissory Notes) will convert such notes into 813,567 post reverse split shares of the Companys common stock.



F-12



---

##### Table of Contents

The Companys obligation to complete the Merger is subject to the fulfillment or waiver
by the Company of customary conditions contained in the Merger. OnPointss obligation to complete the Merger is subject to the fulfillment or waiver by OnPoint of the conditions contained in the Merger Agreement including, but not limited to,
the following conditions:



| |  | the Company shall have completed the Reverse Stock Split;
|- |  | ---------------------------------------------------------



| |  | the VHS Promissory Notes shall have been converted into shares of the Companys common stock;
|- |  | ---------------------------------------------------------------------------------------------



| |  | OnPoint shall have completed a private placement pursuant to which it receives gross proceeds of at least $500,000;
|- |  | -------------------------------------------------------------------------------------------------------------------



| |  | all outstanding liabilities of the Company shall have been satisfied, other than amounts of up to $50,000;
|- |  | ----------------------------------------------------------------------------------------------------------



| |  | OnPoint stockholders shall have approved the Merger;
|- |  | ----------------------------------------------------



| |  | subject to appropriate filings under the Securities and Exchange Act of 1934, as amended, the current officers and directors of the Company shall have
resigned and officers and directors designated by OnPoint shall have been appointed to the Companys Board of Directors and as officers of the Company.
|- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The Merger Agreement may be terminated by either party if the Merger has not been consummated by March 31, 2011. The Merger Agreement may be terminated by the Company if the representations or
warranties provided by OnPoint become inaccurate. The Merger Agreement may be terminated by OnPoint if:



| |  |  | The representations or warranties provided by the Company become inaccurate;
| | - |  | ----------------------------------------------------------------------------



| |  |  | OnPoints due diligence investigation reveals information which varies materially or adversely from the understandings upon which OnPoint agreed
to proceed with the Merger;
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | More than 5% of the OnPoint stockholders exercise dissenters rights; or
| | - |  | ------------------------------------------------------------------------



| |  |  | The Company has suffered any material adverse change from the date of signing the Merger Agreement
| | - |  | --------------------------------------------------------------------------------------------------

Closing of the transactions contemplated by the Merger Agreement is subject to other customary terms and conditions.



F-13